Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study
Authors (first, second and last of 9)
Rheumatology International is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases.
It serves an international, interdisciplinary group of workers involved in problems of rheumatic diseases. Coverage includes the management of rheumatic diseases, and extends to all modern trends in clinical research. Contributions include original publications, short communications, editorials, letters to the editors and reviews. No case reports will be accepted.
- An independent journal reporting on worldwide research, diagnosis and management of rheumatic diseases
- Covers disease management as well as trends in clinical research
- Presents original research, editorials, letters and reviews
- Average time from submission to 1st decision: 21 days
- 97% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Armen Yuri Gasparyan
- Publishing model
- Hybrid (Transformative Journal). How to publish with us, including Open Access
Journal metrics
- 3.580 (2021)
- Impact factor
- 3.247 (2021)
- Five year impact factor
- 13 days
- Submission to first decision (Median)
- 793,777 (2021)
- Downloads
Latest issue
Latest articles
-
-
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study
Authors (first, second and last of 13)
-
Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease
Authors
-
Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
Authors (first, second and last of 4)
-
The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis—a cross-sectional study
Authors (first, second and last of 4)
Journal updates
-
Trending articles from the past 12 months
Find out which Rheumatology International publications are attracting the most attention.
-
New and increased Impact Factor for Rheumatology International
We are delighted to announce that Rheumatology International's 2020 Impact Factor is 2.631. Our Immediacy Index (average number of times an article is cited in the year it is published) has also increased from 0.568 to 1.236. Thank you to all our authors, reviewers and Editors who have made such valuable contributions to the journal!
-
Celebrating editorial excellence
Congratulations to Dr Armen Gasparyan and his editorial team! Rheumatology International is a top rated Springer Nature journal, based on data collected from the Journal Author Satisfaction Survey. We're recognising extraordinary editors for their commitment and passion to their journals. Learn more about editorial excellence.
-
Call for COVID-19 cases
The COVID-19 Global Rheumatology Alliance has launched an international registry for clinicians to enter data about their rheumatology patients with COVID-19. Add your case here: https://rheum-covid.org.
About this journal
- Electronic ISSN
- 1437-160X
- Abstracted and indexed in
-
- ANVUR
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO MasterFILE
- EBSCO STM Source
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information